Gerald Soff

Clinical Research Lead · University of Miami/Jackson Health System

Credentials: · · · · ·

History

Classical Hematology Section · University of Miami/Jackson Health System
Present
University of Miami/Jackson Health System
Present

Hematology and Medical Oncology
Beth Israel Deaconess Medical Center
1984–1987
Internal Medicine
Medical College of Virginia Hospitals
1981–1984
Johns Hopkins School of Medicine
1977–1981

Research

Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
New England Journal of Medicine · 2019 · 567 citations
Combined effects of angiostatin and ionizing radiation in antitumour therapy
Nature · 1998 · 524 citations
High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis
Journal of Clinical Oncology · 2011 · 336 citations

SM
Simon Mantha
14 papers
Alok Khorana
10 papers
JM
Jodi Mones
9 papers
RP
Rekha Parameswaran
8 papers
Hanny Al-Samkari
7 papers
TW
Tzu-Fei Wang
7 papers
MS
Michael Streiff
5 papers
Anaadriana Zakarija
4 papers
DS
Debra Sarasohn
4 papers
Hau Kwaan
4 papers
JZ
Jeffrey Zwicker
4 papers
AT
Ann Traynor
3 papers

Clinical trials

Avatrombopag vs. Placebo for CIT in GI Malignancies
Principal investigator · Completed · Phase 2
Hanny Al-Samkari, MD
2023–2026
Avatrombopag for Thrombocytopenia in People With Cancer
Principal investigator · Withdrawn · Phase 2
Memorial Sloan Kettering Cancer Center
2020
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
Site PI · Recruiting · Phase 2
Novartis Pharmaceuticals
2026–2030